HOME NEWS EARNINGS RESULTS PICKS STRATEGY BLOG CONTACT SUBSCRIBE LOGIN SUBSCRIBE JOIN FREE
LOADING
Price Investing Group
← Back to Research Watchlist
BIO
Bio-Rad Laboratories Inc - Class A
Healthcare Medical Devices · California, USA · Reports in usd
Market Cap: $7.76B
Market Cap
$7.76B
Enterprise Val
$7.61B
P/E Ratio
10.22
P/B Ratio
1.04
Trailing PEG (1Y)
-0.05
As Of
Apr 23, 2026

Overview & Key Metrics

Reporting period: Dec 31, 2025 · Q4 2025
Book Value$7.45B
Gross Margin49.80%
Profit Margin49.80%
Return on Equity10.86%
Return on Assets7.60%
Current Ratio5.62
Debt/Equity0.19
LT Debt/Equity0.18
Revenue Per Share25.70

Income Statement

Dec 31, 2025
Revenue$693.2M
Cost of Revenue$348.0M
Gross Profit$345.2M
R&D$70.3M
SG&A$221.0M
Operating Expenses$464.1M
Operating Income-$118.9M
Interest Expense$12.1M
Tax Expense$209.2M
Net Income$720.0M
EPS (Basic)$26.41
EPS (Diluted)$26.39
EBIT$941.3M
EBITDA$941.3M
Consolidated Income$720.0M
Non-Controlling Interests$0.00

Balance Sheet

Dec 31, 2025
Cash & Equivalents$529.8M
Accounts Receivable$460.6M
Inventory$740.7M
Current Assets$2.91B
LT Investments$6.10B
Property, Plant & Equipment$709.9M
Intangibles$754.1M
Non-Current Assets$7.67B
Total Assets$10.58B
Accounts Payable$129.0M
Current Debt$37.4M
Current Liabilities$517.0M
LT Debt$1.35B
Non-Current Liabilities$2.61B
Total Liabilities$3.12B
Total Debt$1.38B
Retained Earnings$8.18B
Shareholder Equity$7.45B
Shares Outstanding26,974,835

Cash Flow Statement

Dec 31, 2025
Operating Cash Flow$164.9M
Investing Cash Flow-$34.2M
Financing Cash Flow$3.3M
CapEx-$45.8M
Free Cash Flow$119.1M
Depreciation & Amort.$0.00
Stock-Based Comp$0.00
Acquisitions / Disposals$0.00
Investment Activity$11.6M
Debt Issued/Repaid-$200.0K
Equity Issued/Repaid$3.9M
Dividends Paid$0.00
Net Change in Cash$134.0M
Data cached · Meta cache · Daily cache · Statements cache · TTL 24h